BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3078253)

  • 1. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
    Sialer G; Marincek B; Mengden T; Vetter W
    Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adrenal scintigraphy-value and indications in adrenal disease].
    Zechmann W; Bartsch G; Skrabal F; Buchsteiner R
    Helv Chir Acta; 1979 Aug; 46(3):283-6. PubMed ID: 489397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (author's transl)].
    Galanski M; Fischer M; Cramer BM; Friemann J; Vetter H
    Rofo; 1980 Dec; 133(6):629-33. PubMed ID: 6453793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
    García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
    Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
    Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
    Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
    Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
    Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
    Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
    J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
    Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
    Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintigraphic investigations of the adrenals by means of 75Se-selenocholesterol (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1980; 44(4):307-10. PubMed ID: 7243634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
    Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
    Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
    Lindberg S; Ernest I; Fjälling M; Holmdahl C
    Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone.
    Conn JW; Cohen EL; Herwig KR
    J Lab Clin Med; 1976 Nov; 88(5):841-56. PubMed ID: 978047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
    Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic localization of adrenal lesions in primary aldosteronism.
    Gross MD; Shapiro B; Grekin RJ; Freitas JE; Glazer G; Beierwaltes WH; Thompson NW
    Am J Med; 1984 Nov; 77(5):839-44. PubMed ID: 6496538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
    Herwig KR; Sonda LP
    J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.